Misonix (NASDAQ: MSON; Stock Twits: $MSON) recently presented at the MDB Capital Bright Lights Conference in New York City -- the only conference of its kind with an exclusive focus on publicly-traded companies with market changing intellectual property (IP). Misonix was selected as one of 40 public companies out of 1,500 small-cap companies as a technological leader in the medical device field.